A GLP-1 supply disruption is a continuity problem long before it becomes a stock problem. When a manufacturer pauses a presentation or a wholesaler runs dry, the risk is not simply that a patient misses a dose. It is that a settled treatment plan fractures, and a patient who was doing well starts making decisions on their own, from switching brands unadvised to buying from sources nobody in the clinic can vouch for.
Intermittent availability of GLP-1 receptor agonists (GLP-1 RAs) has been a recurring feature of the UK weight management landscape, and summer sharpens it. Holiday demand, stockpiling before travel, and thinner staffing all land in the same weeks. This guide sets out how to prepare a clinic so that a supply gap becomes a managed event with a clear plan, rather than a scramble of individual phone calls.
Why Supply Gaps Test a Weight Management Service
Weight management prescribing depends on rhythm. A patient on a GLP-1 RA is used to a weekly routine, a familiar dose, and a known point of contact. Interrupt that rhythm and the clinical picture can wobble in ways that have little to do with the medicine itself. Anxiety rises, adherence to the wider plan slips, and the patient starts searching for answers wherever they can find them.
The Medicines and Healthcare products Regulatory Agency issues formal notices when a product is disrupted, and the official drug and device alerts are the reference point a clinic should watch rather than social media rumour. Reacting to a verified notice, instead of a patient forwarding a screenshot, keeps the whole team working from the same accurate information and avoids the panic that speculation creates.
Where a supply gap does its damage
- Unadvised switching, where a patient changes product or dose without a clinical review.
- Unsafe sourcing, when someone turns to an unregulated seller to bridge the gap.
- Abrupt stopping, followed by a rushed restart that ignores the usual titration.
- Eroded trust, if the clinic is silent while the patient hears about the shortage elsewhere first.
None of these are dramatic failures of clinical skill. They are the ordinary consequences of a service that has no agreed plan for the days when the usual product is simply not on the shelf.
The Five Steps of a Written Supply Contingency Plan
A contingency plan does not need to be elaborate. It needs to be written, shared with the whole team, and ready before the first notice lands. These five steps take an afternoon to draft and save far more than that once availability tightens.
1Watch the official channels
Assign one person to monitor MHRA notices and manufacturer updates, so the clinic learns of a disruption from a verified source rather than from a worried patient. Early warning buys time to plan calmly.
2Agree the clinical options in advance
Decide, with your prescribers, what the acceptable responses are: reviewing an alternative within licence, adjusting timing, or a planned pause with a safe restart. Agreeing the menu before the pressure hits keeps decisions consistent.
3Write one core patient message
A short, honest script that every team member can deliver: what is happening, what the clinic is doing, and what the patient should and should not do in the meantime. One message avoids the mixed signals that fuel anxiety.
4Set a triage order
Not every patient needs a same day call. Decide who to contact first, usually those mid titration or with a specific clinical concern, and who can wait for a routine review, so limited time reaches the patients who need it most.
5Document every decision
Record what was discussed, what was agreed, and why, for each affected patient. A clear record protects the patient, supports the next clinician, and stands up to any later audit of how the disruption was handled.
Counselling Patients Through a Gap Safely
The single most valuable thing a clinic can offer during a shortage is a calm, competent conversation. A patient who understands why the gap has happened, and what the safe options are, is far less likely to act rashly. The structured consultation approach taught on our GLP-1 agonists and weight management course gives clinicians a repeatable way to have that conversation under pressure, covering expectations, safety netting, and clear next steps without improvising each time.
The most important safety message is a firm one: never source a substitute from an unregulated seller. Patients understandably worry about losing progress, but a fake or mishandled product carries risks that dwarf a temporary pause. Point them instead to trustworthy consumer guidance, such as the MHRA advice on GLP-1 medicines and how to obtain them safely, so the clinic and the patient are working from the same authoritative line.
Jella Kang, who has run weight loss clinics in Liverpool for over 12 years, treats a supply notice as a prompt to reach out rather than wait for the phone to ring. Her view is that a proactive message, sent before patients start to worry, does more for retention and safety than any discount. Building that instinct into a Medical Weight Loss Mastery style consultation system means the response is consistent whoever picks up the case.
Common Mistakes Clinics Make in a Shortage
The first mistake is silence. A clinic that says nothing while stock tightens leaves patients to fill the gap with rumour, and by the time it does communicate, some have already made poor choices. A brief, early, honest note lands far better than a polished statement that arrives too late.
The second mistake is improvised switching, where a well meaning clinician moves a patient to a different product on the spot without a proper review of suitability, dose equivalence, and tolerability. A pre agreed set of options, applied through a normal consultation, avoids the inconsistency that ad hoc decisions create.
The third mistake is letting documentation slip in the rush. When decisions are made quickly and verbally, the record thins out exactly when it matters most. Practitioners who want to pressure test their own contingency plan are welcome to send it through our contact page for trainer feedback before the summer squeeze.
|
JULY
|
Seasonal tip: draft your supply contingency script now, before the holiday demand peak, and make sure every team member can deliver the same core message word for word. |
Turning a Shortage Into a Standing Protocol
The clinics that handle supply disruption well do not reinvent their response each time. They template the plan once, review it after each event, and keep it beside the standard operating procedures the team already follows. Training reinforces this, because a team that shares one consultation and safety netting framework communicates a shortage in one voice. The medicine may be temporarily unavailable, but the care never has to be.
Frequently Asked Questions
How should a clinic first learn about a GLP-1 supply disruption?
From an official source rather than from a patient or social media. Assign one team member to monitor MHRA drug alerts and manufacturer updates, so the clinic hears about a disruption early and from a verified notice. That head start is what allows a calm, planned response instead of a reactive scramble.
Can a patient simply switch to a different GLP-1 product during a shortage?
Not without a clinical review. Different products are not interchangeable dose for dose, and a switch needs a proper assessment of suitability, dose equivalence, and tolerability by a suitably qualified prescriber. The safe approach is a normal consultation applying pre agreed options, never an on the spot change made under time pressure.
What should clinicians tell patients tempted to buy online during a gap?
Be direct: never source a substitute from an unregulated seller. Counterfeit and mishandled products carry serious risks that far outweigh a temporary pause in treatment. Point patients to authoritative MHRA guidance and reassure them that the clinic will help find a safe way through, so they do not feel they have to solve it alone.
Is a planned pause in GLP-1 treatment ever acceptable?
A planned, clinically supervised pause can be a reasonable option when no suitable alternative is available, provided the restart follows the usual titration rather than resuming at the previous dose. The decision, the reasoning, and the restart plan should all be documented, and the patient should know exactly what to expect and when to make contact.
Why does supply disruption feel worse over the summer?
Several pressures land together. Patients often want to stock up before travel, overall demand can rise, and clinics run on lighter staffing during the holiday period. A disruption that would be manageable in a quiet month can feel acute in July or August, which is exactly why a written plan prepared in advance matters most at this time of year.
Does training help a clinic manage a shortage?
Yes, because a shortage is largely a communication and decision making challenge. A team that has worked through the same consultation, expectation setting, and safety netting framework delivers one consistent message and applies options in the same way. That shared approach is what keeps patients safe and reassured when the usual product is unavailable.
Preparing for the Next Supply Gap?
A written plan and a consistent clinical framework turn a supply disruption from a source of risk and lost trust into a managed, almost routine event. If you would like to strengthen the consultation and safety netting skills your whole team relies on, reach us through our contact page, call 07769 003219, or email info@mjclinicaltraining.co.uk. A short conversation now will tell you which course best fits the gap you want to close before the summer peak.
Steady care, even when stock is not
CPD-accredited training from practising clinicians in Wavertree, Liverpool, with mentorship that continues after the course ends.
Last updated: 22 July 2026 by Mohammed Ahmad MPharmS PgDiP PIP and Jella Kang MRPharmS. This article is general professional guidance for clinicians and does not replace the product information for any individual medicine or your own regulator’s standards.